On the edge: Pharmacological evidence for anxiety-related behavior in zebrafish larvae

Behavioural Brain Research

Volumn 228, Issue 1, 2012, Pages 99-106

  Richendrfer, H ^a   Pelkowski, S D ^a   Colwill, R M ^b   Creton, R ^a  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Anxiety; Diazepam; Fluoxetine; High throughput; Thigmotaxis; Zebrafish

Indexed keywords

CAFFEINE; DIAZEPAM; FLUOXETINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; EDGE PREFERENCE; LARVA; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; VISUAL STIMULATION; ZEBRA FISH;

ANIMALS; ANXIETY; CAFFEINE; CUES; DIAZEPAM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FLUOXETINE; SPATIAL BEHAVIOR; SWIMMING; ZEBRAFISH;

EID: 83755229000     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.11.041     Document Type: Article

References (30)

1. Mathur P., Guo S. Use of zebrafish as a model to understand mechanisms of addiction and complex neurobehavioral phenotypes. Neurobiol Dis 2010, 40:66-72.
2. Gerlai R. High-throughput behavioral screens: the first step towards finding genes involved in vertebrate brain function using zebrafish. Molecules 2010, 15:2609-2622.
3. Blackburn J.S., Liu S., Raimondi A.R., Ignatius M.S., Salthouse C.D., Langenau D.M. High-throughput imaging of adult fluorescent zebrafish with an LED fluorescence macroscope. Nat Protoc 2011, 6:229-241.
4. Norton W., Bally-Cuif L. Adult zebrafish as a model organism for behavioural genetics. BMC Neurosci 2010, 11:90.
5. Colwill R.M., Creton R. Locomotor behaviors in zebrafish (Danio rerio) larvae. Behav Process 2011, 86:222-229. (NIHMS264983).
6. Pelkowski S., Kapoor M., Richendrfer H., Wang X., Colwill R.M., Creton R. A novel high-throughput imaging system for automated analyses of avoidance behavior in zebrafish larvae. Behav Brain Res 2011, 223:135-144.
7. Tierney K.B. Behavioural assessments of neurotoxic effects and neurodegeneration in zebrafish. Biochim Biophys Acta 2011, 1812:381-389.
8. Kokel D., Bryan J., Laggner C., White R., Cheung C.Y.J., Mateus R., et al. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol 2010, 6:231-237.
9. Rihel J., Prober D.A., Arvanites A., Lam K., Zimmerman S., Jang S., et al. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 2010, 327:348-351.
10. Champagne D.L., Hoefnagels C.C.M., de Kloet R.E., Richardson M.K. Translating rodent behavioral repertoire to zebrafish (Danio rerio): relevance for stress research. Behav Brain Res 2010, 214:332-342.
11. Miller B.H., Schultz L.E., Gulati A., Su A.I., Pletcher M.T. Phenotypic characterization of a genetically diverse panel of mice for behavioral despair and anxiety. PLoS One 2010, 5:e14458.
12. Gerlai R. Zebrafish antipredatory responses: a future for translational research. Behav Brain Res 2010, 207:223-231.
13. Maximino C., de Brito T.M., da Silva Batista A.W., Herculano A.M., Morato S., Gouveia A. Measuring anxiety in zebrafish: a critical review. Behav Brain Res 2010, 214:157-171.
14. Miller N.Y., Gerlai R. Shoaling in zebrafish: what we don't know. Rev Neurosci 2011, 22:17-25.
15. Pellow S., Chopin P., File S.E., Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985, 14:149-167.
16. Bencan Z., Sledge D., Levin E.D. Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety. Pharmacol Biochem Behav 2009, 94:75-80.
17. Maximino C., da Silva A.W.B., Gouveia A., Herculano A.M. Pharmacological analysis of zebrafish (Danio rerio) scototaxis. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:624-631.
18. Airhart M.J., Lee D.H., Wilson T.D., Miller B.E., Miller M.N., Skalko R.G. Movement disorders and neurochemical changes in zebrafish larvae after bath exposure to fluoxetine (PROZAC). Neurotoxicol Teratol 2007, 29:652-664.
19. Egan R.J., Bergner C.L., Hart P.C., Cachat J.M., Canavello P.R., Elegante M.F., et al. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res 2009, 205:38-44.
20. Buske C., Gerlai R. Shoaling develops with age in Zebrafish (Danio rerio). Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:1409-1415.
21. Colwill R.M., Creton R. Automated imaging of avoidance behavior in larval zebrafish. Neuromethods 2010, Springer Science+Business Media, New York, LLC 2011. A.V. Kalueff, J.M. Cachat (Eds.).
22. Creton R. Automated analysis of behavior in zebrafish larvae. Behav Brain Res 2009, 203:127-136.
23. Colwill R.M., Creton R. Imaging escape and avoidance behavior in zebrafish larvae. Rev Neurosci 2011, 22:63-73.
24. Dadda M., Domenichini A., Piffer L., Argenton F., Bisazza A. Early differences in epithalamic left-right asymmetry influence lateralization and personality of adult zebrafish. Behav Brain Res 2010, 206:208-215.
25. PubChem., NIH: Diazepam: National Library of Medicine; 2006.
26. Wong D.T., Bymaster F.P., Engleman E.A. Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci 1995, 57:411-441.
27. Finn I.B., Holtzman S.G. Tolerance to caffeine-induced stimulation of locomotor activity in rats. J Pharmacol Exp Ther 1986, 238:542-546.
28. El Yacoubi M., Ledent C., Parmentier M., Costentin J., Vaugeois J.M. The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A2A adenosine receptor antagonists. Psychopharmacology 2000, 148:153-163.
29. Smith A. Effects of caffeine on human behavior. Food Chem Toxicol 2002, 40:1243-1255.
30. Maximino C., Lima M.G., Olivera K.R.M., Picanço-Diniz D.L.W., Herculano A.M. Adenosine A1, but not A2, receptor blockade increases anxiety and arousal in zebrafish. Basic Clin Pharmacol Toxicol 2011.